Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 808,524
  • Shares Outstanding, K 20,330
  • Annual Sales, $ 53,910 K
  • Annual Income, $ 12,480 K
  • 60-Month Beta 0.49
  • Price/Sales 14.92
  • Price/Cash Flow 44.38
  • Price/Book 4.46
Trade SLP with:

Options Overview Details

View History
  • Implied Volatility 43.10% ( +1.96%)
  • Historical Volatility 40.29%
  • IV Percentile 17%
  • IV Rank 43.37%
  • IV High 68.41% on 06/17/22
  • IV Low 23.72% on 08/19/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 35
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 236
  • Open Int (30-Day) 395

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/23
See More
  • Average Estimate 0.18
  • Number of Estimates 2
  • High Estimate 0.18
  • Low Estimate 0.17
  • Prior Year 0.21
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.58 +22.18%
on 01/05/23
40.98 -2.88%
on 01/13/23
+1.69 (+4.43%)
since 12/23/22
3-Month
32.58 +22.18%
on 01/05/23
45.02 -11.59%
on 10/27/22
-7.63 (-16.09%)
since 10/26/22
52-Week
32.58 +22.18%
on 01/05/23
67.59 -41.12%
on 08/08/22
+0.20 (+0.51%)
since 01/26/22

Most Recent Stories

More News
Simulations Plus (SLP) Rolls Out New Version of DILIsym

Simulations Plus' (SLP) latest DILIsym version X has a redesigned software infrastructure that includes server/cloud computing functionalities as well as command line and graphical interface options.

JBL : 78.28 (-1.99%)
SLP : 39.80 (+0.08%)
ANET : 123.99 (+2.02%)
PSTG : 28.24 (+2.28%)
Simulations Plus (SLP) Announces $20M Accelerated Buyback Plan

The ASR is a part of earlier announced (December 2022) $50 million share repurchase plan by Simulations Plus (SLP).

JBL : 78.28 (-1.99%)
SLP : 39.80 (+0.08%)
ASUR : 10.14 (-0.59%)
ANET : 123.99 (+2.02%)
Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure

Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division...

SLP : 39.80 (+0.08%)
Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced it has entered into an accelerated share...

SLP : 39.80 (+0.08%)
Simulations Plus (SLP) Q1 Earnings & Revenues Miss Estimates

Simulations Plus' (SLP) Q1 results were affected by lower revenues in Software business segment.

JBL : 78.28 (-1.99%)
SLP : 39.80 (+0.08%)
ASUR : 10.14 (-0.59%)
ANET : 123.99 (+2.02%)
Pre-Market Brief: Stocks Mixed After FOMC Minutes Temper Policy Pivot Hopes

March S&P 500 futures (ESH23) are trending down -0.07% this morning after three major U.S. benchmark indices finished higher in volatile trading on Wednesday as investors digested the release of the Federal...

ESH23 : 4,063.25 (-0.30%)
NXT.LN : 6,584.000 (+1.76%)
VYNT : 0.9000 (+5.88%)
GERN : 3.37 (-0.88%)
AMZN : 99.22 (+2.10%)
SLP : 39.80 (+0.08%)
LAZR : 6.35 (+2.75%)
TMUS : 148.69 (+0.42%)
Simulations Plus (SLP) Q1 Earnings and Revenues Miss Estimates

Simulations Plus (SLP) delivered earnings and revenue surprises of -50% and 3.79%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?

SLP : 39.80 (+0.08%)
OTEX : 33.99 (+2.91%)
Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus: Fiscal Q1 Earnings Snapshot

SLP : 39.80 (+0.08%)
Simulations Plus Reports First Quarter Fiscal 2023 Financial Results

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first quarter...

SLP : 39.80 (+0.08%)
Simulations Plus (SLP) to Report Q1 Earnings: What's in Store?

Simulations Plus' (SLP) first-quarter performance is likely to gain from healthy adoption of its solutions across various verticals.

DAL : 39.22 (-0.41%)
SLP : 39.80 (+0.08%)
TSM : 93.45 (+1.13%)
CFG : 43.12 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 41.12
2nd Resistance Point 40.81
1st Resistance Point 40.31
Last Price 39.80
1st Support Level 39.50
2nd Support Level 39.19
3rd Support Level 38.69

See More

52-Week High 67.59
Fibonacci 61.8% 54.21
Fibonacci 50% 50.08
Fibonacci 38.2% 45.95
Last Price 39.80
52-Week Low 32.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar